GM1b is a new member of antigen for serum antibody in Guillain-Barre syndrome

Neurology

Volumn 47, Issue 1, 1996, Pages 237-242

  Kusunoki, S ^a   Iwamori, M ^b   Chiba, A ^a   Hitoshi, S ^a   Arita, M ^c   Kanazawa, I ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO KASEI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GM1;

ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0030016322     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.1.237     Document Type: Article

References (18)

1. The Guillain-Barré syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096-1104.
2. McKhann GM, Griffin JW, Cornblath DR, et al. Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol 1988;23: 347-353.
3. Ilyas AA, Willison HJ, Quarles RH, et al. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol 1988;23: 440-447.
4. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40:1900-1902.
5. Walsh FS, Cronin M, Koblar S, et al. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J Neuroimmunol 1991; 34:43-51.
6. Ilyas AA, Mithen FA, Dalakas MC, Chen ZW, Cook SD. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 1992;107:111-121.
7. van den Berg LH, Marrink J, de Jager AEJ, et al. Anti-GM1 antibodies in patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1992;55:8-11.
8. Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann Neurol 1993;34:130-135.
9. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911-1917.
10. Kusunoki S, Chiba A, Kon K, et al. N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol 1994;35:570-576.
11. Hartung HP, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and treatment of the Guillain-Barré syndrome-part I. Muscle Nerve 1995;18:137-153.
12. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27(suppl):S21-S24.
13. Iwamori M, Sawada K, Hara Y, et al. Neutral glycosphingolipids and gangliosides of bovine thyroid. J Biochem 1982;91: 1875-1887.
14. Iwamori M, Sunada S, Ishihara E, Moki M, Fujimoto S, Nagai Y. Differential expression of fucosyl GM1 and a disialoganglioside with a NeuAcα2-6GalNAc linkage (GD1e) in various rat ascites hepatoma cells. FEBS Lett 1986;198:66-70.
15. Iwamori M, Sunada S, Ishihara E, et al. Wide distribution of rat hepatoma asialo GM1 and its different responses to antiasialo GM1 antibody-mediated in vitro and in situ cell killing. Jpn J Cancer Res (Gann) 1987;78:621-627.
16. Hirabayashi Y, Hyogo A, Nakao T, et al. Isolation and characterization of extremely minor gangliosides. GM1b and GD1α, in adult bovine brains as developmentally regulated antigens. J Biol Chem 1990;265:8144-8151.
17. Furuya S, Irie F, Hishikawa T, et al. Ganglioside GD1α in cerebellar Purkinje cells: its specific absence in mouse mutants with Purkinje cell abnormality and altered immunoreactivity in response to conjunctive stimuli causing long-term desensitization. J Biol Chem 1994;269:32418-32425.
18. Pestronk A, Cornblath DR, Ilyas AA, et al. A treatable multifocal motor neuropathy with antibody to GM1 ganglioside. Ann Neurol 1988;24:73-78.